Enzo Pays $3.5M To End FCA Medicare Billing Suit
Enzo Biochem Inc. has agreed to pay $3.5 million to settle state and federal False Claims Act allegations that the life sciences company sought to unlawfully increase Medicare and Medicaid profits...To view the full article, register now.
Already a subscriber? Click here to view full article